Tenax Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
TENX
CUSIP
88032L605
Type
Equity
Class
COM NEW
Num filings
13
Total reported value, excl. options
$58.0 k
Manager Report Date Value ($000) Shares Option Type